NAD+ Therapy: What to Know Before You Inject

What Is NAD+ and Why Does It Matter?

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in every cell of your body. It plays a critical role in:

• • Cellular energy production (ATP)
  • DNA repair
  • Mitochondrial function
  • Activation of longevity pathways (like sirtuins)

As we age, NAD+ levels naturally decline, leading to decreased cellular efficiency and increased signs of aging.

Fact: NAD+ Doesn’t Easily Cross Cell Membranes

NAD+ is a large, highly charged, polar molecule. It cannot freely diffuse across most mammalian cell membranes. 

When injected or delivered through an IV, it circulates in the blood but is rapidly broken down by extracellular enzymes (e.g., CD38, CD73) into smaller precursors like nicotinamide (NAM), NMN, or NR. 

These precursors are what actually enter cells via specific transporters and get converted back into NAD+ inside the cell. 

In other words, the “direct cellular refill” narrative is biologically oversimplified. You’re mostly paying for a very expensive way to deliver precursor molecules indirectly.

Common NAD+ Side Effects and Practical Drawbacks

Because NAD+ is metabolically active, rapid increases in blood levels from injections or IVs can cause:

• • Chest tightness
  • Anxiety or “impending doom” sensations
  • Head pressure
  • Flushing, warmth
  • Nausea
  • Gastrointestinal cramping
  • Dizziness or lightheadedness 
  • Headache
  • Muscle pain or fatigue

Side effects are usually transient, but can be significant enough that people have to slow or stop treatment. Infusions also require 2 to 4+ hours in a clinic, carry minor risks of infection or vein irritation, and are expensive with no FDA approval for anti-aging or wellness uses. 

Long-term safety data on repeated high-dose IV NAD+ remain limited, and large-scale outcomes trials are still lacking.

Stronger, Evidence-Based Alternatives: Oral NAD+ Precursors

The most studied and practical approach is oral supplementation with NAD+ precursors, smaller molecules your cells readily absorb and convert efficiently into NAD+. Leading options backed by human trials include Nicotinamide Riboside (NR) and Nicotinamide Mononucleotide (NMN).

These consistently raise blood and cellular NAD+ levels (often 2-fold or more after 2 weeks). A 2026 head-to-head trial in Nature Metabolism showed both NMN and NR approximately doubled circulating NAD+ after 14 days, outperforming nicotinamide (NAM) for sustained elevation. 

Multiple clinical reviews confirm oral NR and NMN demonstrate reliable biochemical target engagement (increased NAD+ metabolites) and are generally well-tolerated for weeks to months. 

Oral precursors are convenient, far more affordable for daily use, and supported by a growing body of pharmacokinetic and safety data, unlike direct NAD+ injections or IVs. 

The Bottom Line 

Direct NAD+ injections are not inherently “bad,” but the science does not support them as the most efficient, evidence-based, or patient-friendly route for most people seeking sustained NAD+ support. 

Precursors like NR and NMN offer a smarter, biologically aligned path that respects how cells actually make and use NAD+.As always in regenerative medicine: test baseline NAD+ status when possible, individualize, and prioritize interventions with the best risk–benefit data. Larger, longer-term human outcomes trials are still needed across all methods, but the precursor data is currently the strongest we have.

Your Next Step

If you’re curious about real regenerative solutions that work with your biology, not against it, we invite you to experience a more advanced approach. Schedule your complimentary consultation at Rejuvience Med Spa and find out what’s possible. There’s no cost, and there’s never any pressure.